biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Response to Finallytherock's AGM Worries

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Dec 17, 2021 12:18pm

111 Views

Post# 34241014

RE:RE:Response to Finallytherock's AGM Worries

Yoiks, that's a long walk off a short pier you're taking, Finallytherock.

I think it's time for the company and Colwell Capital to comment.

I one hundred percent stand behind my comments. I've stated my opinion, I think, in a pretty clear manner.

Maybe it's time for me to shut up for a bit and let the negative stuff fester. After all, it is absolutely against my interests to see the Bioasis share price go up right now, not until Q1 sometime.

So, please, feel free...

jd

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December